2013 American Transplant Congress
Belimumab (Anti-BAFF/BLyS) Effective in a Case of Resistant Antibody Mediated Rejection
Division of Nephrology, University of Washington, Seattle, WA
PURPOSE: Belimumab is a humanized IgG1 monoclonal antibody to B-cell activating factor (BAFF), also known as B-lymphocyte Stimulator (BLyS). BAFF works through three receptors to…2013 American Transplant Congress
Improving the SRTR Methodology Used To Identify Potentially Underperforming Transplant Programs in the United States
In Feb. 2012, SRTR and OPTN jointly hosted a consensus conference on transplant program quality and surveillance. One recommendation was to study Bayesian hierarchical modeling…2013 American Transplant Congress
Early and Late Reuse of Liver Allografts from Brain-Dead Liver Transplant Recipients
Transplant Surgery, Medstar Georgetown transplant Institute, Washington, DC
A unique method of donor pool expansion is the retransplantation of livers from recipients who die (brain-death). The hesitancy to reuse livers is in part…2013 American Transplant Congress
Efficacy and Safety of Single Fixed-Dose Rituximab for Recurrent Glomerulonephritis Post-Transplantation
Barnes-Jewish Hospital, St. Louis, MO; Washington University School of Medicine, St. Louis, MO
Purpose: Rituximab, using a multi-dose regimen based on body surface area, has been used for recurrent glomerulonephritis (GN) post-renal transplant with variable success. We examined…2013 American Transplant Congress
Has the VA Found a Way To Reduce Racial Disparities in Kidney Transplant Evaluation? Preliminary Results from the National VA Kidney Transplant Study
End-stage kidney disease is more common in African Americans (AA) and other minorities (OM) (e.g., Hispanic/Latinos) than Whites (WH). Reports from national data indicate that…2013 American Transplant Congress
Impact of Induction Therapy on Clinical Outcomes and Quality of Life in Aged Kidney Transplant Recipients, The
Division of Transplant Surgery, MUSC, Charleston, SC; Dept of Pharmacy, MUSC, Charleston, SC
Background: In older renal transplant recipients, where death with functioning graft limits life years gained, one of the primary purposes of transplant is to improve…2013 American Transplant Congress
Early Look at Transplant Outcomes from the OPTN KPD Pilot Program: Comparing Cold Times and DGF Rates with Other Living and Deceased Donor Transplants, An
UNOS; Yale Medical Ctr; Univ of Florida; Northwestern Univ; Carnegie Mellon Univ
Purpose: In Dec 2010, the Organ Procurement and Transplantation Network Kidney Paired Donation Pilot Program (OPTN KPDPP) facilitated the first of 27 (through Nov 2012)…2013 American Transplant Congress
What Are the Outcomes from Very Old DCD Kidneys?
Cardiff Nephrology and Transplantation Unit, UHW, Cardiff, United Kingdom
Introduction:Kidney transplantation from elderly donors is still a very controversial topic. In recent years, we have seen an increase in the number of elderly DCD…2013 American Transplant Congress
New Proposed National Allocation Policy for Deceased Donor Kidneys in the U.S. and Its Possible Impact on Patient Outcomes
Introduction:The Organ Procurement and Transplantation Network (OPTN) has proposed a new national kidney allocation policy. Its important features include: allocating kidneys in the top twentieth…2013 American Transplant Congress
LCP-Tacro Improves TAC-Induced Tremors: Preliminary Analysis of Switching STudy of Kidney TRansplant PAtients with Tremor to LCP-TacrO (STRATO): An Exploratory Study
Neurotoxicity occurs in up to 50% of kidney transplant recipients (KTR). Tremor is the most common manifestation of neurotoxicity. It is believed that Tacrolimus (TAC)…
- « Previous Page
- 1
- …
- 144
- 145
- 146
- 147
- 148
- …
- 178
- Next Page »